|biomedical-market-news.com_0001 - 2005-05-09 sacserv.com utterly insulting disclaimer|
So now, by not deleting our addresses from the drivel that THEY decided to send to us unsolicited, we now have an ongoing business relationship? Legal or not, this is just way too over the top. This is a company guaranteed to anger and annoy recipients. All of their clients will also suffer being tarnished (or worse) by association. This is definately a company to avoid and block in any way possible.
Here is the entire email for your amusement:
From email@example.com Mon May 9 18:01:26 2005 [2005-05-09 18:01:26 126454]
Received: from mail.sacserv.com (mail.sacserv.com [22.214.171.124])
by www.munged.ext (8.11.6/8.11.6) with SMTP id j49M1PB11424
; Mon, 9 May 2005 18:01:26 -0400
Received: (qmail 24628 invoked from network); 9 May 2005 21:25:28 -0000
Received: from unknown (HELO mail9.sacserv.com) (127.0.0.1)
by 0 with SMTP; 9 May 2005 21:25:28 -0000
Date: Mon, 9 May 2005 16:25:28 -0500 (CDT)
Subject: BMN PRESS RELEASE: PDA 2005 Extractables/Leachables Forum, May 23-25 2005
BMN PRESS RELEASE
Contact: Wanda Neal
PDA Director, Programs & Meetings
301-656-5900 ext 111 phone
PDA 2005 EXTRACTABLES/LEACHABLES FORUM
-- Keynote Speaker: Moheb N. Nasr PhD, Director, Office of New Drug Chemistry, DCER, FDA
-- May 23-25 2005 -- Bethesda MD
BETHESDA MD USA -- MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) -- MAY 09 2005 -- This 2-1/2 day forum on May 23-25 focuses on the analytical, material, regulatory and toxicology issues pertaining to container and closure qualification for extractables and leachables. Actionable strategies will be presented for developing the organizational team framework to qualify container/closure systems, drug delivery systems and process material for use with drug and combination products. Additionally, this forum will provide current guidance and capture industry's best practices for conducting qualification studies.
PDA is honored to host Dr. Moheb N. Nasr, as the keynote speaker for this event. He is currently the Director, Office of New Drug Chemistry, CDER, at the FDA.
The comprehensive agenda for the forum covers the 4 key areas of materials, chemistry, toxicology and regulatory, and is packed with information, including:
-- 6 new case studies
-- 7 Materials presentations stressing the collaborative nature of addressing extractables/leachables issues
-- 4 Chemistry presentations focusing on the latest analytical methods and protocols to detect, identify and quantify extractables
-- 7 presentations providing US, European and Canadian perspectives on Toxicology and Regulatory
-- 4 roundtable discussions providing opportunities to get answers to your specific questions
-- 4 panel discussions
WHEN & WHERE:
The conference will be held May 23-25 at the Marriott Bethesda North, in Bethesda MD.
For hotel/venue information, go to:
TO REGISTER ONLINE:
To register online or via fax or mail, go to:
FOR FURTHER INFORMATION, PLEASE CONTACT:
Director, Programs & Meetings
3 Bethesda Metro Ctr Ste 1500
Bethesda MD USA 20814
301-656-5900 ext 111 phone
Please forward this press release to colleagues who may want to read it.
EDITOR'S NOTE: The opinions, claims/statements in this press release are solely those of the author. The Medical Industry E-mail News Service(TM) & BMN Inc accept no legal liability/responsibility for its contents/transmission.
According to legal experts & federal requirements, this press release FULLY complies w/the CAN-SPAM Act, each of its provisions, & all applicable/current state/federal laws & regulations. This electronic newsletter & daily news transmittal service are Constitutionally-protected publications. Like the wire services, these are PAID transmittals of a news announcement & newsletter -- not an advertisement -- via the "Medical Industry E-Mail News Service(TM)." It's the world's 1st/largest, press release/newsletter distribution service focused exclusively on the medical product mfg industry.
ADD ME: If you/colleagues want to be added to this comp press release distribution list, please click below, or email: firstname.lastname@example.org http://sacserv.com/links.jsp?linkid=19819&subid=3412705&campid=141636&type=0
READERSHIP: Pass-around e-mail forwarding generates a total readership of approx. 300,000-500,000 persons in almost 200 countries. Includes: valuable middle to top mgmt, key execs, decision-makers & regulatory affairs professionals at almost every US medical product mfgr/supplier & medical service provider. Over 800 leading medical trade associations, major universities, medical ctrs/hospitals, medical publishers, medical product mfg/service providers, law firms, regulatory organizations, US Federal Govt, & economic devel organizations, often use our E-mail News Service(TM).
TO ORDER: To place an order to transmit your press release to over 200,000 individual e-mail addresses of medical industry execs worldwide, please contact BMN Inc: email@example.com or click below to charge your 1st order:
2770 S Harbor Bl Ste H
Santa Ana CA USA 92704-5835
Delete/Add/Change Requests: We honor all delete requests. To be removed from this distribution list, or to change/add your email #, please follow the simple instructions below. Or, forward the entire press release to: firstname.lastname@example.org & type: "Please Delete" in the subjectline. That way we can use computer coding at the tail end to correctly match it to your exact email #. Please allow 1-3 business days to take effect. Not asking to be deleted means that you consent to receive press releases & confirms there is an ongoing business correspondent relationship.
To be removed from future e-mail transmittals, please click on the following link or copy and paste it into your web browser and press the RETURN key. http://sacserv.com/unsubscribe.jsp?subid=3412705&custid=76&campid=141636
Useful contact information from their website includes toll free numbers:
Biomedical Market Newsletter
3237 Idaho Pl
Costa Mesa CA USA 92626-2707
800-875-8181 toll free phone
The domain name they use for sending is sacserv.com. If anyone from this organization should happen to read this article, please note and remember this: We don't care if your spam is legal. If it is, it's legal spam, unrequested and unwanted. Just because it's CAN-SPAM compliant doesn't make it not spam.
TOASTEDspam.com toasted spam dot com